Is this the path to end allergic reactions? - Innovation Tor

Unlike most therapeutic antibodies already available on the market, the new antibody does not necessarily have to be injected into the body

Related Keywords

Germany , German , Edzard Spillner , Nick Laursen , Lars Kruse , Marburg Giessen , Department Of Engineering , Department Of Molecular Biology , Aarhus University , Molecular Biology ,